Bingqian Liu

Bingqian Liu

Auto-generated profile, based on publicly available information

Bingqian Liu

Electric Power Research Institute of State Grid Fujian Electric Power Co., Ltd., Fuzhou 350007, China

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 August 2020 in IEEE Access
Verified
Journal Article
Open access
HNHuanhuan Nie
Huanhuan Nie
YCYing Chen
Ying Chen
Yue XiaYue Xia
Yue Xia
SHShaowei Huang
Shaowei Huang
BLBingqian Liu
Bingqian Liu
Extreme disasters may cause the power supply to the distribution system (DS) to be interrupted. The DS is forced to operate in island mode and forms an islanded microgrid (MG). In order to improve the post-disaster resilience of the DS and to provide longer power supply for as many loads as possible with limited generation resources, this paper proposes a multi-agent deep reinforcement learning (DRL) method which realizes a dual control on the source and load sides of the MG. The problem of resilience improvement is converted to a sequential decision making problem, where the objective is to maximize the cumulative MG utility value over the power outage duration. A multi-agent DRL model is proposed to solve the sequential decision making problem. A dual control policy including energy storage management and load shedding strategy is put forward to maximize the utility value of the MG. A reinforcement learning (RL) environment based on OpenAI and OpenDSS for islanded MG is constructed as a simulator, which has a general interface compatible with, and also can be published to, OpenAI Gym. Numerical simulations are performed for an MG equipped with wind turbines, diesel generators, and storage devices to validate the effectiveness of the proposed method. The influences of available generation resources and power outage duration on the control policy are discussed, which validates the strong adaptability of the proposed method in different conditions.

17 November 2019 in Acta Ophthalmologica
Verified
Journal Article
Open access
PDF file
BLBingqian Liu
Bingqian Liu
Shida ChenShida Chen
Shida Chen
YLYonghao Li
Yonghao Li
PLPing Lian
Ping Lian
XZXiujuan Zhao
Xiujuan Zhao
LLLin Lu
Lin Lu
Objective: To compare the efficacy and safety of macular buckling and vitrectomy for myopic traction maculopathy showing macular schisis (MS) and associated macular detachment (MD) but without full‐thickness macular hole (FTMH).Design: Prospective, randomized, parallel, open‐label study.Methods: Patients were randomly assigned to either buckling or vitrectomy group. Macular buckling and intravitreal C3F8 gas injection were performed in the buckling group. Small gauge vitrectomy, internal limiting membrane peeling (ILMP) and C3F8 gas tamponade were performed in the vitrectomy group. The patients were followed for 12 months.Main outcome measures: Best‐corrected visual acuity (BCVA) at 12 months.Results: A total of 85 patients were randomized, 80 eyes were included (41 receiving buckling, 39 received vitrectomy), and 78 patients completed the study. There were less eyes determined as surgical failure and required a second surgery in the buckling group than vitrectomy the group (2.4% versus 18.4%, p = 0.021). After surgery, macular buckling achieved more improvement in BCVA (+21.7 versus +4.5 Early Treatment Diabetic Retinopathy Study (ETDRS) letters, p = 0.002). FTMH development was observed in only 1 (2.4%) eye, after removing of the implant due to recurrent conjunctival erosion, in the buckling group and 10 (26.3%) eyes (seven with‐, three without MD) in the vitrectomy group (p < 0.001). More eyes developed cataracts in the vitrectomy group than did in the buckling group (28.9% versus 7.5%, p = 0.014). Macular buckling‐associated strabismus (esotropia), binocular diplopia and implant exposure were observed in limited cases.Conclusions and relevance: Macular buckling is superior to vitrectomy with ILM peeling plus gas injection for surgical treatment of MS and associated MD in high myopia.